Heavy Menstrual Bleeding and Iron Deficiency Anemia

NCT05079815 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2023-02-08

No results posted yet for this study

Summary

In the present study, we test the ability of AMSS as a simple tool to identify women with HMB who have ID/ IDA. We will compare the AMSS score to patients' hemoglobin and serum ferritin in women with self-reported HMB and women with normal menstrual flow.

Conditions

  • Heavy Menstrual Bleeding

Interventions

DIAGNOSTIC_TEST

CBC and serum ferritin

take blood sample for CBC and serum ferritin

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2024-05-01
Completion
2025-05-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05079815 on ClinicalTrials.gov